hydrazine has been researched along with Cancer of the Fallopian Tube in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghajanian, C; Bonebrake, AJ; Dewdney, SB; Johnston, CM; Kauderer, JT; Monk, BJ; Moxley, KM; Secord, AA; Ueland, FR | 1 |
1 trial(s) available for hydrazine and Cancer of the Fallopian Tube
| Article | Year |
|---|---|
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Fallopian Tube Neoplasms; Female; Humans; Hydrazines; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms | 2018 |